Feasibility of a clinic‐based, multicomponent hydroxyurea adherence intervention for adolescents and young adults with sickle cell disease
- 17 June 2024
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (9) , e31144
Abstract
Despite the effectiveness of hydroxyurea, adherence remains low for adolescents and young adults (AYA) living with sickle cell disease (SCD). This study evaluated the feasibility, acceptability, and initial efficacy of a clinic‐based, multicomponent (e.g., storytelling, problem solving) intervention with 20 AYA living with SCD. Results found that adherence significantly improved from intervention to follow‐up 1 [t(19) = −2.213, p = .039]. AYA also were generally satisfied with the intervention. These findings, although promising, should be replicated on a larger scale.Keywords
This publication has 8 references indexed in Scilit:
- Pilot randomized controlled clinical trial of an adherence social norms intervention for adolescents with epilepsyEpilepsy & Behavior, 2023
- Effect of Counselling on Compliance of Hydroxyurea Therapy and Frequency of Hospital Admissions among Patients with Sickle Cell Disease- A Longitudinal StudyJournal of Clinical and Diagnostic Research, 2022
- Hydroxyurea (hydroxycarbamide) for sickle cell diseaseCochrane Database of Systematic Reviews, 2022
- Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescentsAnnals of Medicine, 2022
- Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design ApproachJMIR mHealth and uHealth, 2020
- Medication Adherence Apps: Review and Content AnalysisJMIR mHealth and uHealth, 2018
- Barriers to hydroxyurea adherence and health‐related quality of life in adolescents and young adults with sickle cell diseaseEuropean Journal of Haematology, 2017
- A Simple, Novel Method for Assessing Medication AdherenceJournal of Addiction Medicine, 2011